Drugs / ɛ-Aminocaproic Acid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02639819 | Jun 2016 → Jul 2017 | intracerebral hemorrhage | The University of Texas Health Science Center at San Antonio | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ɛ-Aminocaproic Acid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02639819 ↗ |
| Route | Intravenous | “Intervention: intravenous ε-Aminocaproic Acid within 3 hours of symptom onset” NCT02639819 ↗ |